Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564
- 30 April 1999
- journal article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 6 (4), 251-263
- https://doi.org/10.1016/s1074-5521(99)80040-4
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Current Issues in the Enzymology of Mitomycin C Metabolic ActivationGeneral Pharmacology: The Vascular System, 1998
- 1a-Docosahexaenoyl Mitomycin C: A Novel Inhibitor of Protein Tyrosine KinaseBiochemical and Biophysical Research Communications, 1998
- FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndromeCancer Chemotherapy and Pharmacology, 1998
- FR900482, a close cousin of mitomycin C that exploits mitosene-based DNA cross-linkingCell Chemical Biology, 1997
- The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activityPharmacology & Therapeutics, 1997
- DNA−DNA Interstrand Cross-Linking by FR66979: Intermediates in the Activation CascadeJournal of the American Chemical Society, 1997
- Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9General Pharmacology: The Vascular System, 1996
- Review: Anti-infectives Novel mitomycin derivativesExpert Opinion on Therapeutic Patents, 1995
- Microbial mutagenicity and in vitro chromosome aberration induction by FK973, a new antitumor agentMutation Research Letters, 1994
- 3-Amino-5-hydroxybenzoic acid in antibiotic biosynthesis VI. Directed biosynthesis studies with ansamycin antibiotics.The Journal of Antibiotics, 1983